Publication | Closed Access

Combination Therapy With Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients With Type 2 Diabetes: A Real-World Evidence Study

Metabolic SyndromeDiabetes ManagementDiabetesPharmacologyType 2PharmacotherapyCombination TherapyDiabetes MellitusMedicineSodium-glucose Cotransporter 2